• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    Mirati Therapeutics, Inc. (MRTX)

    -NasdaqCM
    25.82 Down 0.84(3.15%) 4:00PM EDT
    |After Hours : 25.82 0.00 (0.00%) 4:34PM EDT
    Add to Portfolio
    Prev Close:26.66
    Open:26.48
    Bid:25.80 x 600
    Ask:25.86 x 100
    1y Target Est:43.60
    Beta:1.34157
    Next Earnings Date:N/A
    Day's Range:25.56 - 27.24
    52wk Range:13.69 - 37.43
    Volume:113,349
    Avg Vol (3m):144,135
    Market Cap:423.82M
    P/E (ttm):N/A
    EPS (ttm):-3.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MRTX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.35
    Quarterly EPS Est (Sep-15) :-0.85
    Mean Recommendation*:1.2
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mirati Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of products targeting oncology. Its clinical stage product candidates include MGCD265, a multi-targeted kinase inhibitor that is in Phase 1b clinical develo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback